
Sign up to save your podcasts
Or


Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.
By The Spondylitis Association of America (SAA)4.8
3131 ratings
Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.

90,933 Listeners

38,824 Listeners

113,035 Listeners

8,826 Listeners

99,722 Listeners

9,236 Listeners

41 Listeners

189 Listeners

66 Listeners

30 Listeners

2 Listeners

156 Listeners

1,284 Listeners

3,646 Listeners